Introduction
============

Sepsis is still a major healthcare problem to be fully recognized worldwide and causes a high number of deaths each year. The current estimates are about 30 million cases and six million deaths every year ([@ref-6]; [@ref-15]). The main reason for this is that there is still no effective specific anti-sepsis treatments. Thus, management of patients with sepsis depends mainly on early recognition allowing correct therapeutic measures to be started rapidly including administration of appropriate antibiotics, source control measures when necessary, and resuscitation with intravenous fluids and vasoactive drugs when needed ([@ref-3]). Thankfully, researchers have fully recognized that due to the dynamic nature of the disease, such as the cytokine profile changes with time, the underlying infection can move from being localized to disseminated, and the immunological profile can change from being proinflammatory to more immunosuppressed ([@ref-22]; [@ref-23]). Then, in the third consensus on sepsis or sepsis-3, it is defined as a life-threatening condition of organ dysfunction caused by a dysregulated host's immune response to infection ([@ref-17]). The question remaining is whether therapeutic interventions that target specific immune process mechanisms implicated in the pathophysiological changes of sepsis might further improve therapeutic effects and save additional lives. The World Health Organization announced sepsis as a global health priority on May 26, 2017 by taking the resolution to improve the prevention, diagnosis, and management of this deadly disease ([@ref-15]). Similarly, the number of articles related to immunotherapy of sepsis reached a peak in 2017. Generally speaking, the number of published articles and citations are essential indicators of the scientific productivity of a country. Bibliometric analysis is usually used to describe the importance of published articles and show research trends on specific topics which can guide future research and provide evidence for clinical practice ([@ref-1]).

Bibliometric analysis has been widely used in medical research. Besides critical care medicine ([@ref-21]), it also includes traumatology ([@ref-4]), emergency medicine ([@ref-13]), neurosurgery ([@ref-1]), oncology ([@ref-2]), gynecology ([@ref-9]), pediatrics ([@ref-11]), and psychology ([@ref-18]) and so on.

To date, bibliometric analysis has not been applied to the field of immunotherapy for sepsis. Therefore, we focus on exploring the characteristics of scientific research productivity in this field. In this way, we can understand the research trends and define some leading countries, which will help us strengthen international cooperation in this field, promote the common progress of the discipline, and ultimately benefit patients.

A comprehensive bibliometric analysis absolutely can't be separated from a reliable and complete database. The Scopus database is the world's largest abstract and citation database of peer-reviewed literature, with more than 19,500 peer-reviewed journals across various disciplines being indexed, covering research topics across all scientific and technical disciplines, ranging from medicine and social sciences to arts and humanities ([@ref-7]). For example, all MEDLINE-indexed journals are covered by Scopus, and it is also one of the commonly used databases in the analysis of medical research results ([@ref-7]; [@ref-10]). Scopus features smart tools to track, analyze and visualize research. What's more, daily data updates enable us to obtain current, reliable data. These salient features are entirely in line with our needs, so we chose it for our research.

Materials and Methods
=====================

Literatures searching
---------------------

On March 16, 2019, we performed advanced retrieval in the Scopus database with no restriction on the language or time. We've summed up eight main search terms, including "sepsis," "severe sepsis," "pyemia," "pyohemia," "pyaemia," "septicemia," "blood poisoning," and "immunotherapy." The fuzzy matching mode was selected for each search term to ensure the completeness and comprehensiveness of the retrieval results. Finally, our retrieval type was "TITLE (sepsis) OR TITLE (severe sepsis) OR TITLE (pyemia) OR TITLE (pyohemia) OR TITLE (pyaemia) OR TITLE (septicemia) OR TITLE (blood poisoning) AND ALL (immunotherapy)." With this approach, we recorded and reviewed 1,483 articles. Our title-specific search for sepsis was intended to make the results more representative and to avoid the proliferation of search results since sepsis is a life-threatening condition of organ dysfunction, concerning a variety of diseases.

Bibliometrics analysis
----------------------

We used the analysis tool in the Scopus database to record the basic information of articles, such as distributions in different medical departments, publication titles, authors, countries, and journals. We took the number of available literature to be an indicator of the number of scientific research achievements. The number of citations is considered an important index of the attention and influence degree of the published papers ([@ref-5]). The primary outcomes were the number of articles attributed to each year and each country, as well as the citations attributed to each paper. In terms of the number of literature published, we focused on the top 10 authors, journals and countries, as well as the top 10 most-cited articles. These were summarized by the descriptive analysis. Secondly, we explored and evaluated the potential correlations between the number of publications of different countries and their gross domestic product (GDP). Based on the World Bank national accounts data and the Organization for Economic Co-operation and Development National Accounts data files, we obtained the data of these different countries' GDP in 2017.

Statistical analysis
--------------------

All statistical analyses were performed using SPSS software version 20.0 (SPSS Inc, Chicago, IL, USA). The Spearman rank correlation test determined the statistical significance of the correlation. \|*r*\| \< 0.3 indicates a weak correlation, 0.3\< \|*r*\| \< 0.5 indicates low correlation, 0.5 \< \|*r*\|\< 0.8 indicates significant correlation, 0.8 \< \|*r*\| \< 1 indicates high correlation, *r* \> 0 indicates two variables are positively correlated, *r* \< 0 indicates two variables negatively correlated, *r* = 0 indicates two variables are irrelevant. *P* \< 0.01 was considered to be statistically significant.

Results
=======

General information
-------------------

We checked the Scopus database and found 1,483 pieces of relevant documents, which included Article, Review, Editorial, Conference Paper, Book Chapter, Letter, Note, Short Survey, and Article in Press. Among them, the top 10 of all the articles were selected for summary and analysis ([Fig. 1](#fig-1){ref-type="fig"}). The number of articles published in 2009--2019 (*n* = 866) increased by 156% compared to the number of articles published in 1989--2008 (*n* = 554) and by 315% compared to the number of articles published in 1999--2008 (*n* = 275). As of March 16, 2019, the total citation of all the articles was 48,125, and the number of median citations was seven, which indicated a relatively attention and influence degree of overall literature. The highest cited article was "Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012" (times cited = 3,435), followed by "The third international consensus definitions for sepsis and septic shock (sepsis-3)" with 2,859, and "The pathophysiology and treatment of sepsis" with 2,711. The top 10 most-cited articles were shown in [Table 1](#table-1){ref-type="table"}. The number of their median citations is 1,175.

![The distribution of publications about immunotherapy for sepsis on the Scopus database in each year.\
Note: 1963, 1965, 1966, 1968, 1969, 1971, 1972, 1973, 1976, 1980 published the number of articles is zero, so it is not presented in the diagram.](peerj-07-7116-g001){#fig-1}
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###### Top 10 most-cited articles about immunotherapy of sepsis.

![](peerj-07-7116-g002)

  Title                                                                                                                                                                      Publication year   Journals (citescore 2017)                 First author                 Country   Scopus citations
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ ----------------------------------------- ---------------------------- --------- ------------------
  Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012                                                                 2013               Critical Care Medicine (3.24)             Dellinger, Richard Phillip   US        3,435
  The third international consensus definitions for sepsis and septic shock (sepsis-3)                                                                                       2016               JAMA (7.30)                               Singer, Mervyn               UK        2,859
  The pathophysiology and treatment of sepsis                                                                                                                                2003               New England Journal of Medicine (14.75)   Hotchkiss, Richard S.        US        2,711
  Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012                                                                 2013               Intensive Care Medicine (3.99)            Dellinger, Richard Phillip   US        2,409
  Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial   1994               JAMA (7.30)                               Fisher, Charles J.           US        842
  Immunosuppression in patients who die of sepsis and multiple organ failure                                                                                                 2011               JAMA (7.30)                               Boomer, Jonathan S.          US        666
  Novel strategies for the treatment of sepsis                                                                                                                               2003               Nature Medicine (16.81)                   Riedemann, Niels Christoph   Germany   635
  Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy                                                                                              2013               Nature Reviews Immunology (17.43)         Hotchkiss, Richard S.        US        593
  A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis                                                     1991               JAMA (7.30)                               Greenman, Richard L.         US        583
  Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: A phase III, randomized, double-blind, placebo-controlled, multicenter trial                        1997               Critical Care Medicine (3.24)             Opal, Steven M.              US        553

Distributions
-------------

The country with most publication counts was the United States of America (USA) which has published 604 articles (41%), and the second productive country was China with 163 (11%), followed by Germany (*n* = 158, 11%) ([Table 2](#table-2){ref-type="table"}).
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###### The top 10 countries with publications about immunotherapy for sepsis and ranked by the publication numbers.

![](peerj-07-7116-g003)

  Countries/Territories   Record count   \% of 1,483
  ----------------------- -------------- -------------
  US                      604            41
  China                   163            11
  Germany                 158            11
  UK                      100            7
  France                  81             5
  Netherlands             69             5
  Canada                  47             3
  Italy                   40             3
  Australia               39             3
  Japan                   39             3

Combining [Table 2](#table-2){ref-type="table"} with [Table 3](#table-3){ref-type="table"}, we can clearly see that the combined scientific output of the first three countries exceeds 50% of the total output. Moreover, these gains are concentrated in countries with higher GDP.
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###### The data of 62 different countries with publications and ranked by GDP (current US \$) in 2017.

![](peerj-07-7116-g004)
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  Countries              GDP (million \$)
  ---------------------- ------------------------------------------
  US                     19,390,604
  China                  12,237,700
  Japan                  4,872,137
  Germany                3,677,439
  UK                     3,622,434
  India                  2,597,491
  France                 2,582,501
  Brazil                 2,055,506
  Italy                  1,934,798
  Canada                 1,653,043
  Russian Federation     1,577,524
  Korea, Rep.            1,530,751
  Australia              1,323,421
  Spain                  1,311,320
  Mexico                 1,149,919
  Indonesia              1,015,539
  Turkey                 851,102
  Netherlands            826,200
  Saudi Arabia           683,827
  Switzerland            678,887
  Argentina              637,590
  Taiwan                 579,302[^a^](#table-3fn1){ref-type="fn"}
  Sweden                 538,040
  Poland                 524,510
  Belgium                492,681
  Thailand               455,221
  Iran, Islamic Rep.     439,514
  Austria                416,596
  Norway                 398,832
  United Arab Emirates   382,575
  Israel                 350,851
  South Africa           349,419
  Ireland                333,731
  Denmark                324,872
  Singapore              323,907
  Malaysia               314,500
  Philippines            313,595
  Colombia               309,191
  Pakistan               304,952
  Chile                  277,076
  Finland                251,885
  Egypt, Arab Rep.       235,369
  Portugal               217,571
  Czech Republic         215,726
  Romania                211,803
  New Zealand            205,853
  Greece                 200,288
  Kazakhstan             159,407
  Hungary                139,135
  Ethiopia               80,562
  Panama                 61,838
  Bulgaria               56,832
  Croatia                54,849
  Lithuania              47,168
  Serbia                 41,432
  Latvia                 30,264
  Nepal                  24,472
  Cyprus                 21,652
  Zimbabwe               17,846
  Georgia                15,081
  Armenia                11,537
  Cuba                   8,713[^b^](#table-3fn2){ref-type="fn"}

**Notes:**

We obtained the data of GDP of Taiwan from CIA "The World Factbook" rather than from World Bank.

We obtained the data of GDP of Cuba in 2015 rather than in 2017.

The journal that published the highest number of original articles was Critical Care Medicine with 65 (4%), followed by Shock (*n* = 55, 4%), and Critical Care (*n* = 35, 2%). Their median CiteScore is 4.23. ([Table 4](#table-4){ref-type="table"}).
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###### Top 10 journals about immunotherapy for sepsis ranked by the number of the publications.
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  Journals                                                     CiteScore 2017   Record count   \% of 1,483
  ------------------------------------------------------------ ---------------- -------------- -------------
  Critical Care Medicine                                       3.24             65             4
  Shock                                                        2.75             55             4
  Critical Care                                                4.53             35             2
  PLOS ONE                                                     3.01             30             2
  American Journal of Respiratory and Critical Care Medicine   5.10             25             2
  Journal of Immunology                                        4.57             23             2
  Intensive Care Medicine                                      3.99             21             1
  Frontiers in Immunology                                      5.62             20             1
  Journal of Infectious Diseases                               4.47             19             1
  Infection and Immunity                                       3.43             17             1

The most prolific author was Opal, S.M., who has 33 articles (2%), followed by Hotchkiss, R.S. (*n* = 29, 2%), and Vincent, J.L. with 20 (1%). ([Table 5](#table-5){ref-type="table"}).
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###### The top 10 authors with publications about immunotherapy for sepsis and ranked by the publication numbers.

![](peerj-07-7116-g007)

  Authors             Record count   \% of 1,483
  ------------------- -------------- -------------
  Opal, S.M.          33             2
  Hotchkiss, R.S.     29             2
  Vincent, J.L.       20             1
  Monneret, G.        17             1
  Coopersmith, C.M.   16             1
  Dunn, D.L.          16             1
  Moldawer, L.L.      15             1
  Shankar-Hari, M.    15             1
  Van Der Poll, T.    14             1
  Venet, F.           14             1

Moreover, based on the data of the World Bank, we obtained the data from different countries' GDP in 2017 ([Table 3](#table-3){ref-type="table"}) and ranked by their GDP. Spearman rank correlation analysis revealed that there was a highly positive correlation between GDP of different countries and the publication numbers (*r* = 0.811, *P* \< 0.001).

Discussion
==========

After evaluating 57 years of research, we have clearly recognized that sepsis is associated with the activation of multiple inflammatory pathways and that sepsis can also lead to an immunosuppressive state. That is to say, some patients with "sepsis" clearly show evidence of hyperinflammation (e.g., meningococcal shock), other patients or immunosuppressive condition that could leave patients more susceptible to secondary nosocomial infections ([@ref-19]). Therefore, as an important adjuvant therapy, immunomodulatory therapy has attracted more and more attention from sepsis researchers. Over the past 10 years, medical workers have made considerable achievements in the field and the description of sepsis-induced immune dysfunctions has improved ([@ref-20]). Our bibliometric analysis demonstrated that the number of articles published in the last decade has a sharp increase of 315% compared with those published in the previous decade. In addition, the number of median citations of all the articles was five. We have identified a variety of mechanisms that cause immunosuppression in patients with sepsis, including vast apoptosis-induced depletion of lymphocytes and dendritic cells, decreased expression of the cell-surface antigen presenting complex HLA-DR, and increased expression of the negative costimulatory molecules programmed death 1 (PD-1), cytotoxic T-lymphocyte associated antigen 4, and B- and T-lymphocyte attenuator, and their corresponding ligands (e.g., PD-1 ligand \[PD-L1\]), as well as the numbers of regulatory T cells and myeloid-derived suppressor cells are increased, and there is a shift from a phenotype of inflammatory type 1 helper T (Th1) cells to an antiinflammatory phenotype of type 2 helper T (Th2) cells characterized by the production of interleukin-10 ([@ref-8]). What's more, the management of patients with sepsis will necessitate more rigorous approaches to disease description and stratification ([@ref-24]; [@ref-25]; [@ref-26]) and for the immunotherapy to be rational and effective, the immunocompetence of a patient at a given stage of disease has to be evaluated ([@ref-14]). For the future, we believe that the prevention of sepsis-induced immunosuppression, or its treatment if it occurs, is a research priority ([@ref-8]). At the same time, investment in both basic and translational clinical science should be increased with the aim of achieving two goals: to identify new treatment targets and strategies, focusing on those that can help patients the world over, including patients with sepsis who live in low-income and middle-income countries; and to develop the application of the principles of personalized medicine to the treatment of sepsis ([@ref-3]). These goals cannot be achieved without the support of the World Health Organization, as well as increased funding from governments and the efforts of researchers ([@ref-15]). And the findings suggested a booming development of immunotherapy of sepsis with active research activity.

Now we can see the extensive use of bibliometric analysis to detect worldwide scientific productions ([@ref-1]; [@ref-2]; [@ref-4]; [@ref-9]; [@ref-11]; [@ref-13]; [@ref-18]; [@ref-21]). Bibliometric analysis is frequently used to evaluate the quality of scholarly work because subjective factors do not influence it. The citation has been used as an index for assessing the value of literature. To a certain extent, the high citation articles are of more significant impact and analysis of top-cited original articles may show useful information on the specific research field ([@ref-5]). We also ranked the top 10 most-cited articles about immunotherapy of sepsis and summarized their basic information such as title, publication year, journals, first author, country, and Scopus citations ([Table 1](#table-1){ref-type="table"}). The significance of this bibliometric analysis is that it is the first time to use the method to obtain global research information in the field of immunotherapy for sepsis. We were astonished to find that 70% of the 10 articles were published in top international journals, including JAMA (The Journal of the American Medical Association), New England Journal of Medicine, Nature Medicine, and Nature Reviews Immunology. In 2013, the two critical care journals that published the same sepsis guidelines together and the number of citations for these guidelines ranked first in the field. Moreover, the number of their median citations is 1,175, which indicated that they expounded the critical scientific research achievements, so they have attracted wide attention.

After this study, we confirmed the dominant influence of the USA in the field of immunotherapy for sepsis. The number of publications from the USA was far more than any other country, accounting for about 41%, and was more than the number of articles from the second country to the sixth (China, Germany, UK, France, and the Netherlands) ([Table 2](#table-2){ref-type="table"}). Also, as previously analyzed, the US published eight of the top 10 most cited articles. It was revealing that the USA produced both large quantities and high impact articles.

Additionally, Pearson correlations pointed out that countries with high GDP tend to make more contributions to the field of immunotherapy for sepsis. The reason for this pattern is usually that countries with high GDP have relatively abundant research funds, better national policies, sound medical infrastructure (e.g., advanced intensive care facilities) and excellent medical staff reserved ([@ref-15]). In this case, if the long-term steady growth of publications in this area is to be maintained, governments need to substantially increase investment and work to improve health infrastructure, especially in low- and middle-income countries ([@ref-16]). Only with the support of these robust research findings can our policymakers and health care practitioners use this as a basis for intervention and improvement in clinical practice ([@ref-12]; [@ref-19]).

In general, this bibliometric analysis provides a macroscopic perspective for the immunotherapy of sepsis, which can be used to predict future research trends, guide funding policies, and provide practical and useful help for the decision-making of government workers and medical researchers who are interested in this field.

Of course, there are some limitations to this study, and we need to be aware of them. First, we only searched the Scopus database so the single data search strategy may have resulted in incomplete data collection. Second, since there is always some controversial literature, some researchers do not believe that highly cited research is equal to high-quality research. We also did not account for self-citations in the analysis. Also, detailed GDP investment in this area may be representative, but it is a complex task and challenging to complete. However, we still believe that such a large amount of macro data and such detailed literature analysis are enough to represent the development trend of this research field. Finally, we believe that researchers can ignore a tiny number of potentially missing publications and that our results are sufficient to represent the trends in this field.

Conclusions
===========

To sum up, this is the first bibliometric study evaluating the worldwide productivity in the field of immunotherapy for sepsis and we found that countries with high GDP tend to make more contributions to the field. The number of articles published in this field has been growing, especially in the last decade, when the number of articles has exploded. Whether measured by the total number of publications or the impact of the articles, the US is the strongest. Moreover, the journal that published the highest number of articles was Critical Care Medicine. The results of this series of analyses are intended to help policymakers and relevant researchers promote further development in this field.
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